Anidulafungin Patent Expiration
Anidulafungin is Used for treating fungal infections. It was first introduced by Vicuron Holdings Llc
Anidulafungin Patents
Given below is the list of patents protecting Anidulafungin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eraxis | US6960564 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
Apr 12, 2021
(Expired) | Vicuron Holdings |
| Eraxis | US7709444 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
Apr 12, 2021
(Expired) | Vicuron Holdings |
| Eraxis | US5965525 | Cyclic peptide antifungal agents |
Feb 17, 2020
(Expired) | Vicuron Holdings |
Anidulafungin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List